<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04470102</url>
  </required_header>
  <id_info>
    <org_study_id>188</org_study_id>
    <nct_id>NCT04470102</nct_id>
  </id_info>
  <brief_title>Edge-to-edge Mitral Valve Repair in the Surgical Treatment for Hypertrophic Cardiomyopathy</brief_title>
  <acronym>PRIZMA-pilot</acronym>
  <official_title>A Randomised Controlled Pilot Trial: Edge-to-edge Mitral Valve Repair in the Surgical Treatment for Hypertrophic Cardiomyopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meshalkin Research Institute of Pathology of Circulation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meshalkin Research Institute of Pathology of Circulation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective of the study: to evaluate whether edge-to-edge technique improves clinical and
      hemodynamic results in patients scheduled to septal myectomy for severely symptomatic
      hypertrophic obstructive cardiomyopathy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomised controlled pilot trial to evaluate whether edge-to-edge technique improves
      clinical and hemodynamic results in patients scheduled to septal myectomy for severely
      symptomatic hypertrophic obstructive cardiomyopathy. Patients with proven hypertrophic
      cardiomyopathy and resting left ventricle outflow tract obstruction underwent septal
      myectomy. If patients were suitable for both surgical techniques, they were randomized to
      septal myectomy + edge-to-edge mitral valve repair or isolated septal myectomy. All surgeons
      were experienced at least 50 related procedures.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 12, 2020</start_date>
  <completion_date type="Anticipated">January 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A randomized clinical trial comparing mitral valve repair using the edge-to-edge technique for surgical treatment of hypertrophic cardiomyopathy</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>no data</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Left Ventricular Outflow Tract (LVOT) gradient</measure>
    <time_frame>12 months in the medium-term follow-up</time_frame>
    <description>Gradient at the level of the output section of the left ventricle after surgery (mmHg) This measurement will be performed by transthoracic echocardiography at rest and / or during exercise. The Doppler method will be used.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Systolic anterior motion of the mitral valve</measure>
    <time_frame>12 months in the medium-term follow-up</time_frame>
    <description>Systolic anterior motion of the mitral valve after surgery This measurement will be performed by transthoracic echocardiography at rest and / or during exercise.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Hypertrophic Obstructive Cardiomyopathy</condition>
  <arm_group>
    <arm_group_label>isolated septal myectomy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Isolated extended septal myectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Septal myectomy+ &quot;edge-to-edge&quot;</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>advanced septal myectomy in combination with mitral valve repair using the edge-to-edge technique</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>mitral valve repair by edge-to-edge technique</intervention_name>
    <description>transaortic access for mitral valve repair edge-to-edge</description>
    <arm_group_label>Septal myectomy+ &quot;edge-to-edge&quot;</arm_group_label>
    <other_name>Alfieri stitch</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Septal myectomy</intervention_name>
    <description>isolated extended septal myectomy</description>
    <arm_group_label>isolated septal myectomy</arm_group_label>
    <other_name>Septal myectomy (SM)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Provide written informed consent (either from the patient or a substitute
             decision-maker)

          -  Indications for surgical treatment (septal myectomy) of hypertrophic cardiomyopathy

        Exclusion Criteria:

          -  indications for mitral valve replacement

          -  Patient failure at any stage of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander V. Bogachev-Prokophiev, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>E.Meshalkin National medical research center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexander V. Bogachev-Prokophiev, MD, PhD</last_name>
    <phone>+73833476029</phone>
    <email>bogachev.prokophiev@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sergei A. Budagaev</last_name>
    <phone>+73833476029</phone>
    <email>ser.bud.med@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>&quot;E.Meshalkin National medical research center&quot; of the Ministry of Health of the Russian Federation</name>
      <address>
        <city>Novosibirsk</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander V. Bogachev-Prokophiev, MD, PhD</last_name>
      <phone>+73833476029</phone>
      <email>bogachev.prokophiev@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Sergei Budagaev</last_name>
      <phone>89021606921</phone>
      <email>ser.bud.med@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 8, 2020</study_first_submitted>
  <study_first_submitted_qc>July 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 14, 2020</study_first_posted>
  <last_update_submitted>July 19, 2020</last_update_submitted>
  <last_update_submitted_qc>July 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>edge-to-edge repair</keyword>
  <keyword>mitral valve plastic (MVP)</keyword>
  <keyword>Septal myectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Cardiomyopathy, Hypertrophic</mesh_term>
    <mesh_term>Hypertrophy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

